Navigation Links
Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results
Date:7/21/2009

                          Wednesday, August 5, 2009
                                9:00 a.m. EDT

                               1-800-731-5774

                Webcast:http://www.nucryst.com/web_casts.htm

PRINCETON, NJ, July 21 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. invites analysts and investors to participate in a briefing on Wednesday, August 5, with David B. Holtz, Interim President Chief Executive Officer, and Chief Financial Officer, regarding the Company's 2009 second quarter results.

The briefing, via conference call, is set for 9:00 a.m. EDT. To participate, please call the toll-free number 1-800-731-5774. In addition to standard disclosure over wire services, a news release with the second quarter results will be posted on the NUCRYST web site prior to the call. To listen to the call live on the Internet, please go to http://www.nucryst.com/web_casts.htm.

The briefing will be recorded and available for re-broadcast on demand for seven days by dialing 1-877-289-8525. Callers will need to provide the operator with the following reservation number: 21309904 followed by the number sign. An audio file of the call will also be archived on the NUCRYST web site.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.

    Acticoat(TM) is a trademark of Smith & Nephew plc
    SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.


'/>"/>
SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
2. Weight Watchers Announces Second Quarter 2009 Earnings Conference Call
3. STERIS Corporation Announces Date of Fiscal 2010 First Quarter Earnings Release and Conference Call
4. Feel Fun, Fit & Fabulous! At the 2009 Womens Health Conference
5. Scholarships Available for PA Breast Cancer Coalition Annual Conference
6. Echo Therapeutics to Present at Jessup & Lamont 2009 Growth Stock Conference
7. Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference
8. Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
9. Pelosi House Leaders, Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act
10. Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference
11. NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology: